Melissoidesin G, a diterpenoid purified from Isodon melissoides, induces leukemic-cell apoptosis through induction of redox imbalance and exhibits synergy with other anticancer agents | |
Yu, Zu-Yin; Liang, Yu-Guang; Xiao, He; Shan, Ya-Jun; Dong, Bo; Huang, Rui; Fu, Ya-Li; Zhao, Zhen-Hu; Liu, Ze-Yuan; Zhao, Qin-Shi; Wang, Sheng-Qi; Chen, Jia-Pei; Mao, Bing-Zhi; Cong, Yu-Wen | |
2007-11-01 | |
发表期刊 | INTERNATIONAL JOURNAL OF CANCER |
ISSN | 0020-7136 |
卷号 | 121期号:9页码:2084-2094 |
摘要 | Melissoidesin G (MOG) is a new diterpenoid purified from Isodon melissoides, a plant used in Chinese traditional medicine as antitumor and anti-inflammatory agents. In our study, MOG was shown to specifically inhibit the growth of human leukemia cell lines and primary acute myeloid leukemia (AML) blasts via induction of apoptosis, with the evidence of mitochondrial Delta Psi m loss, reactive oxygen species production, caspases activation and nuclear fragmentation. Furthermore, it was shown that thiol-containing antioxidants completely blocked MOG-induced mitochondrial Delta Psi m loss and subsequent cell apoptosis, while the inhibition of apoptosis by benzyloxy-carbonyl-Val-Ala-Asp-fluoromethylketone only partially attenuated mitochondrial Delta Psi m loss, indicating that MOG-induced redox imbalance is an early event upstream to mitochondrial Delta Psi m loss and caspase-3 activation. Consistently, it was found that MOG rapidly decreased the intracellular glutathione (GSH) content in a dose-dependent manner and the significance of GSH depletion in MOG-induced apoptosis was further supported by the protective effects of tert-butyl hvdroquinone (tBHQ) and the facilitative effects of DL-buthionine (S,R)-sulfoximine (BSO). Furthermore, it was showed that GSH depletion induced by MOG rendered some leukemia cell lines more sensitive to arsenic trioxide (As2O3), doxorubicin or cisplatin. Additionally, the synergistic apoptotic effects of 1106 with As2O3 were detected in HL-60 and primary AML cells, but not in normal cells, suggesting the selective toxicity of their combination to the malignant cells. Together, we proposed that MOG alone or administered with other anticancer agents may provide a novel therapeutic strategy for leukemia. (C) 2007 Wiles-Liss. Inc. |
关键词 | Melissoidesin g Leukemia Apoptosis Redox Arsenic Trioxide |
收录类别 | sci |
语种 | 英语 |
WOS记录号 | WOS:000249718100026 |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.kib.ac.cn/handle/151853/1683 |
专题 | 植物化学与西部植物资源持续利用国家重点实验室 |
作者单位 | 1.Beijing Inst Radiat Med, Dept Pathophysiol, Beijing 100850, Peoples R China 2.Beijing 307 Hosp, Acad Med Sci, Dept Clin Pharmacol, Beijing, Peoples R China 3.Chinese Acad Med Sci, Inst Basic Med Sci, Dept Mol Immunol, Beijing 100730, Peoples R China 4.Chinese Acad Med Sci, Kunming Inst Bot, Dept Phytochem, Kunming, Yunnan, Peoples R China |
推荐引用方式 GB/T 7714 | Yu, Zu-Yin,Liang, Yu-Guang,Xiao, He,et al. Melissoidesin G, a diterpenoid purified from Isodon melissoides, induces leukemic-cell apoptosis through induction of redox imbalance and exhibits synergy with other anticancer agents[J]. INTERNATIONAL JOURNAL OF CANCER,2007,121(9):2084-2094. |
APA | Yu, Zu-Yin.,Liang, Yu-Guang.,Xiao, He.,Shan, Ya-Jun.,Dong, Bo.,...&Cong, Yu-Wen.(2007).Melissoidesin G, a diterpenoid purified from Isodon melissoides, induces leukemic-cell apoptosis through induction of redox imbalance and exhibits synergy with other anticancer agents.INTERNATIONAL JOURNAL OF CANCER,121(9),2084-2094. |
MLA | Yu, Zu-Yin,et al."Melissoidesin G, a diterpenoid purified from Isodon melissoides, induces leukemic-cell apoptosis through induction of redox imbalance and exhibits synergy with other anticancer agents".INTERNATIONAL JOURNAL OF CANCER 121.9(2007):2084-2094. |
条目包含的文件 | 下载所有文件 | |||||
文件名称/大小 | 文献类型 | 版本类型 | 开放类型 | 使用许可 | ||
201111010048.pdf(894KB) | 开放获取 | -- | 浏览 下载 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论